AIC
NXTC icon

AWM Investment Company’s NextCure NXTC Stock Holding History

AWM Investment Company’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Hold
117,371
– – 0.14% 86
2025
Q4 		$1.67M Buy
+117,371
New +$1.22M 0.16% 89

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

AWM Investment Company's NXTC Position: Q1 2026 in Review

AWM Investment Company held its NextCure (NXTC) position steady in Q1 2026 at 117,371 shares worth $1.23M. The position accounts for 0.14% of the portfolio, ranked #86.

AWM Investment Company first reported a position in NXTC in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.67M in Q4 2025. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • AWM Investment Company held 117,371 shares of NextCure worth $1.23M as of Q1 2026.
  • AWM Investment Company left its NextCure share count unchanged in Q1 2026.
  • NextCure made up 0.14% of AWM Investment Company's portfolio in Q1 2026, its #86 holding.
  • AWM Investment Company first reported a position in NextCure in Q4 2025 and has held it in 2 quarters since.
  • AWM Investment Company's NextCure position peaked at $1.67M in Q4 2025.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.